An Open-label Phase 1b Study of ORIC-533 in Patients with Relapsed or Refractory Multiple Myeloma
NOT ENROLLING
Trial ID:
NCT05227144 Protocol # :
22-610
Phase
I
Disease Sites
Multiple Myeloma
Principal Investigator
Nadeem, Omar
Trial Description
Call 877-DF-TRIAL (877-338-7425) to learn more about this clinical trial, protocol #22-610
22-610